CLL Topics Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2007
NCT00596336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

CLL Topics, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

inactivated influenza vaccine (1 trial)

Drugs in Phase 1 Trials (1)

poly-iclc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lymphoma (Phase 1)

Lymphoma, T-Cell (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2